[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Yuki et al., 1992 - Google Patents

Improved serodiagnosis of chronic hepatitis C in Japan by a second‐generation enzyme‐linked immunosorbent assay

Yuki et al., 1992

Document ID
11241501486209218507
Author
Yuki N
Hayashi N
Hagiwara H
Takehara T
Oshita M
Kasahara A
Fusamoto H
Kamada T
Publication year
Publication venue
Journal of medical virology

External Links

Snippet

To clarify the role of hepatitis C virus (HCV) infection in chronic liver disease, sera from Japanese patients which were negative by the original anti‐HCV assay (Ortho) were subjected to a second‐generation anti‐HCV assay based on a combination of structural …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • C12Q1/707Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
    • C12N2770/00011MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse Transcribing DNA Viruses
    • C12N2730/00011Reverse Transcribing DNA Viruses
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus

Similar Documents

Publication Publication Date Title
Hagiwara et al. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α
Féray et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation
Mita et al. Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer
Ohkoshi et al. Prevalence of antibody against non‐A, non‐B hepatitis virus in Japanese patients with hepatocellular carcinoma
Yamada et al. Hepatitis C virus genotypes are not responsible for development of serious liver disease
Féray et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis
Chu et al. The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B
Yuki et al. Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma
Shih et al. Serum hepatitis B virus DNA in healthy HBsAg‐negative Chinese adults evaluated by polymerase chain reaction
Sheu et al. Prevalence of anti‐HCV and HCV viremia in hemodialysis patients in Taiwan
TANAKA et al. Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: a multi‐institution analysis
Kao et al. Mixed infections of hepatitis C virus as a factor in acute exacerbations of chronic type C hepatitis
Zignego et al. “Inapparent” hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease
Yuki et al. Improved serodiagnosis of chronic hepatitis C in Japan by a second‐generation enzyme‐linked immunosorbent assay
Al‐Faleh et al. Hepatitis C virus genotypes in patients with chronic liver disease and haemodialysis patients from Saudi Arabia
Ohkoshi et al. Detection of hepatitis C virus RNA in sera and liver tissues of non‐A, non‐B hepatitis patients using the polymerase chain reaction
Takeda et al. Hepatitis C virus infection in hepatocellular carcinoma. Detection of plus‐strand and minus‐strand viral RNA
Wang et al. Posttransfusion hepatitis revisited by hepatitis C antibody assays and polymerase chain reaction
Tuveri et al. Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections
Yuki et al. HCV RNA and antibody to HCV core protein in Japanese patients with chronic liver disease
Kakumu et al. Long‐term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C
Ichimura et al. Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease
Song et al. Markers of hepatitis C and B virus infections among blood donors in Ho Chi Minh City and Hanoi, Vietnam.
Yuki et al. Serodiagnosis of chronic hepatitis C in Japan by second-generation recombinant immunoblot assay
Yuki et al. Clinical characteristics and antibody profiles of chronic hepatitis C patients: relation to hepatitis C virus genotypes